Condias Combi

Condias Combi combines Metformin Hydrochloride and Sitagliptin for oral use. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes. It is manufactured by Belupo D.D. in the EU.

Condias Combi is primarily used to improve glycemic control in adults with type 2 diabetes. Metformin Hydrochloride works by decreasing the amount of sugar produced by the liver and improving the body's response to insulin. Sitagliptin helps to increase the levels of incretin hormones, which stimulate the pancreas to produce more insulin. Together, these active ingredients aim to lower blood sugar levels effectively.

Common effects of Condias Combi may include gastrointestinal discomfort, such as nausea, diarrhea, or stomach pain, particularly when starting the medication. Some users may also experience headache, dizziness, or a metallic taste in the mouth. These effects are generally mild and may subside as the body adjusts to the medication.

Condias Combi should be used with caution in individuals with kidney or liver problems. It is important to monitor blood sugar levels regularly and consult a healthcare provider before starting this medication. Patients should also be aware of the signs of low blood sugar, such as sweating, shakiness, and confusion, and know how to manage them.

Condias Combi may interact with other medications, including those that affect blood sugar levels, such as insulin or other diabetes medications. It is also important to be cautious when taking this medication with alcohol, as it can increase the risk of low blood sugar. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.